Get 40% Off
🤑 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Canopy Growth woes continue: will its California asset sale be enough to appease analysts?

Published 2023-06-29, 01:57 p/m
© Reuters.  Canopy Growth woes continue: will its California asset sale be enough to appease analysts?
GSPTSE
-
WEED
-

Proactive Investors - Shareholders of Canopy Growth (TSX:WEED) Corporation (TSX:WEED, NYSE:CGC) suffered another blow on Thursday as the company announced it had finalized the sale of its California cannabis facility.

The news came on the heels of a string of misfortunes for the Canadian cannabis company, which had once been regarded as a success story in the burgeoning sector.

Far from its 2018 heyday, Canopy is now in the midst of an organizational transformation, which aims to reduce spending and streamline operations.

Since April 1, Canopy has sold a total of five facilities, generating $81 million in proceeds. The company expects to raise up to $150 million from additional facility sales by September 30.

The move is part of Canopy’s desperation to shore up its bottom line, after reporting a fourth-quarter net loss of $648 million and booking asset impairment and restructuring costs of $164 million during the period.

The Modesto facility sale likely won’t be enough to appease analysts who are expressing doubts about the company's ability to reduce its cash burn and turn around its operations.

Benchmark, for instance, has slashed its price target on the company to zero after Canopy shares have suffered a significant decline of 78% this year. Its market capitalization has plummeted from C$25 billion in 2021 to less than C$400 million, leading to its expulsion from the S&P/TSX Composite Index earlier this month.

The company is mired in a fiercely competitive marijuana market amidst a lack of progress on federal legislation in the United States.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Benchmark analysts criticized the company's aggressive expansion into the US market, considering the federal illegality of marijuana, suggesting it might indicate a sense of desperation.

In addition to the facility sale, Canopy Growth has made changes to its accounting firm. The company has appointed PKF O'Connor Davies LLP as its new accounting firm while accepting the resignation of KPMG LLP from the role. According to Canopy, the decision was reached jointly between the company and KPMG.

But analysts are still skeptical about Canopy management's ability to turn around the company's performance. Citing the company's acknowledgment of a going concern risk in its latest annual report, Benchmark stated that Canopy "may not be able to continue operations and meet its financial obligations."

Even if the US were to legalize marijuana at the federal level, that may not be enough to save the struggling company, according to analysts, as it continues to burn cash at a staggering rate.

What the future holds for Canopy – and its shareholders – is anyone’s guess.

Read more on Proactive Investors CA

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.